Zacks: Analysts Predict Option Care Health, Inc. (NASDAQ: OPCH) to Report EPS of $ 0.10

Equity research analysts expect Option Care Health, Inc. (NASDAQ: OPCH) to report earnings of $ 0.10 per share for the current quarter, Zack reports. Five analysts released Option Care Health earnings estimates, with the highest EPS estimate being $ 0.10 and the lowest estimate being $ 0.09. Option Care Health posted earnings of $ 0.01 per share in the same quarter last year, suggesting a positive year-over-year growth rate of 900%. The company is expected to release its next quarterly results on Tuesday, November 2.

According to Zacks, analysts expect Option Care Health to report annual earnings of $ 0.55 per share for the current fiscal year, with EPS estimates ranging from $ 0.48 to $ 0.64. For the next fiscal year, analysts expect the company to report earnings of $ 0.86 per share, with EPS estimates ranging from $ 0.70 to $ 1.11. Zacks earnings per share averages are an average based on a survey of research companies that track Option Care Health.

Option Care Health (NASDAQ: OPCH) last released its quarterly earnings data on Tuesday, August 3. The company reported EPS of $ 0.18 for the quarter, beating Thomson Reuters’ consensus estimate of $ 0.08 of $ 0.10. The company posted revenue of $ 860.27 million in the quarter, compared to analysts’ estimates of $ 783.92 million. Option Care Health recorded a return on equity of 4.75% and a net margin of 1.51%. Option Care Health quarterly revenue increased 16.1% year-on-year. During the same period of the previous year, the company made EPS ($ 0.04).

Several research analysts have weighed in on the company recently. Canaccord Genuity increased its price target on Option Care Health from $ 22.00 to $ 24.00 and gave the stock a “buy” rating in a research report published on Wednesday, August 4. Barrington Research raised its price target on Option Care Health from $ 24.00 to $ 28.00 and rated the stock as “outperforming” in a Wednesday August 4 research note. TheStreet upgraded Option Care Health from a “c” rating to a “b-” rating in a research note on Tuesday August 17th. Zacks investment research upgraded Option Care Health from a “sell” rating to a “keep” rating and set a price target of $ 23.00 for the stock in a research note on Thursday, August 5. Finally, Lake Street Capital increased its price target on Option Care Health from $ 27.00 to $ 35 and gave the company a “buy” rating in a research note on Monday, August 30. One analyst rated the stock with a conservation rating and six gave the company a buy rating. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $ 25.56.

OPCH shares traded up $ 0.33 during trading hours on Friday, reaching $ 24.59. The company had a trading volume of 13,978 shares, compared to its average volume of 1,519,232. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.22 and a current ratio of 1. 60. The stock has a fifty-day moving average of $ 23.90 and a 200-day moving average of $ 21.02. The company has a market cap of $ 4.42 billion, a price-to-earnings ratio of 91.07 and a beta of 1.16. Option Care Health has a 12-month low of $ 12.48 and a 12-month high of $ 28.21.

Meanwhile, director Timothy P. Sullivan sold 20,700,000 shares of the company in a transaction that took place on Thursday, August 5. The stock was sold at an average price of $ 20.25, for a total transaction of $ 419,175,000.00. The sale was disclosed in a legal file with the SEC, which is available at this hyperlink. In addition, director Madison Dearborn Partners Llc sold 9,200,000 shares of the company in a transaction on Thursday, September 9. The shares were sold for an average price of $ 26.90, for a total value of $ 247,480,000.00. Disclosure of this sale can be found here. 47.00% of the shares are currently held by insiders of the company.

A number of hedge funds and other institutional investors have recently bought and sold shares in the company. FMR LLC increased its stake in Option Care Health shares by 58.6% in the 2nd quarter. FMR LLC now owns 16,053,322 shares of the company valued at $ 351,086,000 after purchasing an additional 5,933,454 shares during the last quarter. Vanguard Group Inc. increased its position in Option Care Health shares by 21.8% in the second quarter. Vanguard Group Inc. now owns 10,109,441 shares of the company valued at $ 221,093,000 after purchasing an additional 1,807,802 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Option Care Health stocks by 38.5% during the second quarter. Price T Rowe Associates Inc. MD now owns 8,666,112 shares of the company valued at $ 189,528,000 after purchasing an additional 2,408,728 shares in the last quarter. BlackRock Inc. increased its position in Option Care Health shares by 26.6% in the second quarter. BlackRock Inc. now owns 7,702,222 shares of the company valued at $ 168,449,000 after purchasing an additional 1,617,819 shares during the last quarter. Finally, Park West Asset Management LLC increased its position in Option Care Health shares by 1.1% during the first quarter. Park West Asset Management LLC now owns 6,369,932 shares of the company valued at $ 113,003,000 after purchasing an additional 67,730 shares during the last quarter. Hedge funds and other institutional investors hold 57.68% of the company’s shares.

About Option Care Santé

Option Care Health, Inc is committed to providing home and alternative site infusion services. The practice is responsible for the clinical management of infusion therapy, nursing support and care coordination. It also offers anti-infective, nutritional support, heart failure, chronic inflammatory disorders, immunoglobulin, bleeding disorders, women’s health, neurological disorders and specialized therapies.

Featured article: What is the yield curve?

Get a Free Copy of Zacks’ Research Report on Option Care Health (OPCH)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $ 1,000 in Option Care Health now?

Before you consider Option Care Health, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the wider market takes hold of… and Option Care Health was not on the list.

While Option Care Health currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.

See the 5 actions here